The source of MHC class I presented peptides and its implications

Current Opinion in Immunology

Volumn 40, Issue , 2016, Pages 117-122

  Apcher, Sébastien ^a   Prado Martins, Rodrigo ^b   Fåhraeus, Robin ^b,c,d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PEPTIDE; PIONEER TRANSLATION PRODUCT; UNCLASSIFIED DRUG; ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CHLAMYDIASIS; CROSS PRESENTATION; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; RNA TRANSLATION; SALMONELLOSIS; VIRUS INFECTION; ALTERNATIVE RNA SPLICING; ANIMAL; GENETICS; HUMAN; METABOLISM;

ALTERNATIVE SPLICING; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CROSS-PRIMING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PEPTIDES;

EID: 84963517897     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.04.002     Document Type: Review

References (29)

1. Yewdell J.W., Anton L.C., Bennink J.R. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?. J Immunol 1996, 157:1823-1826.
2. Coulie P.G., Lehmann F., Lethe B., Herman J., Lurquin C., Andrawiss M., Boon T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci U S A 1995, 92:7976-7980.
3. Guilloux Y., Lucas S., Brichard V.G., Van Pel A., Viret C., De Plaen E., Brasseur F., Lethe B., Jotereau F., Boon T. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med 1996, 183:1173-1183.
4. Malarkannan S., Horng T., Shih P.P., Schwab S., Shastri N. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 1999, 10:681-690.
5. Uenaka A., Ono T., Akisawa T., Wada H., Yasuda T., Nakayama E. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 1994, 180:1599-1607.
6. Shastri N., Schwab S., Serwold T. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 2002, 20:463-493.
7. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012, 12:557-569.
8. Yewdell J.W. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011, 32:548-558.
9. Catipovic B., Dal Porto J., Mage M., Johansen T.E., Schneck J.P. Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med 1992, 176:1611-1618.
10. Apcher S., Daskalogianni C., Lejeune F., Manoury B., Imhoos G., Heslop L., Fahraeus R. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A 2011, 108:11572-11577.
11. Khan S., de Giuli R., Schmidtke G., Bruns M., Buchmeier M., van den Broek M., Groettrup M. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol 2001, 167:4801-4804.
12. Apcher S., Manoury B., Fahraeus R. The role of mRNA translation in direct MHC class I antigen presentation. Curr Opin Immunol 2012, 24:71-76.
13. Ishigaki Y., Li X., Serin G., Maquat L.E. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 2001, 106:607-617.
14. Maquat L.E., Tarn W.Y., Isken O. The pioneer round of translation: features and functions. Cell 2010, 142:368-374.
15. Schwanhausser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
16. Apcher S., Millot G., Daskalogianni C., Scherl A., Manoury B., Fahraeus R. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci U S A 2013, 110:17951-17956.
17. Norbury C.C., Basta S., Donohue K.B., Tscharke D.C., Princiotta M.F., Berglund P., Gibbs J., Bennink J.R., Yewdell J.W. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004, 304:1318-1321.
18. Wolkers M.C., Brouwenstijn N., Bakker A.H., Toebes M., Schumacher T.N. Antigen bias in T cell cross-priming. Science 2004, 304:1314-1317.
19. Zinkernagel R.M. On the role of dendritic cells versus other cells in inducing protective CD8+ T cell responses. Front Immunol 2014, 5:30.
20. Eisenlohr L.C., Hackett C.J. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. J Exp Med 1989, 169:921-931.
21. Tewari M.K., Sinnathamby G., Rajagopal D., Eisenlohr L.C. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat Immunol 2005, 6:287-294.
22. Miller M.A., Ganesan A.P., Luckashenak N., Mendonca M., Eisenlohr L.C. Endogenous antigen processing drives the primary CD4(+) T cell response to influenza. Nat Med 2015, 21:1216-1222.
23. Apcher S., Daskalogianni C., Manoury B., Fahraeus R. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation. PLoS Pathog 2010, 6:e1001151.
24. Kwun H.J., da Silva S.R., Shah I.M., Blake N., Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J Virol 2007, 81:8225-8235.
25. Lopez-Medina M., Perez-Lopez A., Alpuche-Aranda C., Ortiz-Navarrete V. Salmonella modulates B cell biology to evade CD8(+) T cell-mediated immune responses. Front Immunol 2014, 5:586.
26. Fiegl D., Kagebein D., Liebler-Tenorio E.M., Weisser T., Sens M., Gutjahr M., Knittler M.R. Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells. J Immunol 2013, 190:2791-2806.
27. Perrin A.J., Jiang X., Birmingham C.L., So N.S., Brumell J.H. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr Biol 2004, 14:806-811.
28. Grauling-Halama S., Schenk S., Bubert A., Geginat G. Linkage of bacterial protein synthesis and presentation of MHC class I-restricted Listeria monocytogenes-derived antigenic peptides. PLoS ONE 2012, 7:e33335.
29. Wolf B.J., Princiotta M.F. Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway. J Immunol 2013, 190:2501-2509.